Patent office cements priority for Crispr gene editing in cells chemistryworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from chemistryworld.com Daily Mail and Mail on Sunday newspapers.
The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office (USPTO) has sided with the Broad Institute over the University of California (UC), the University of Vienna, and CRISPR pioneer and Nobel co-laureate Emmanuelle Charpentier, PhD, (collectively called CVC) in the bitter battle royal over who invented the gene-editing technology in eukaryotic cells.
Senti Bio Adds Prominent Scientific and Industry Leaders to its Scientific Advisory Board - read this article along with other careers information, tips and advice on BioSpace